Login to Your Account



Washington Roundup

SEC: Insider Trading Ring Led to $1.7M in Illegal Profits

By Catherine Shaffer
Staff Writer

Wednesday, November 21, 2012
According to the SEC, an insider trading ring based out of Celgene Corp., Sanofi SA and Stryker Corp. was counting on a lack of resources for enforcement at the agency to evade discovery. Those hopes were dashed Monday.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription